Truvestments Capital’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $490K | Sell |
4,733
-173
| -4% | -$15.4K | 0.07% | 225 |
|
|
2026
Q1 | $352K | Hold |
4,906
| – | – | 0.06% | 241 |
|
|
2025
Q4 | $389K | Sell |
4,906
-828
| -14% | -$65.3K | 0.07% | 210 |
|
|
2025
Q3 | $432K | Sell |
5,734
-36
| -0.6% | -$2.47K | 0.08% | 195 |
|
|
2025
Q2 | $398K | Buy |
5,770
+9
| +0.2% | +$590 | 0.08% | 180 |
|
|
2025
Q1 | $390K | Buy |
5,761
+121
| +2% | +$7.24K | 0.08% | 170 |
|
|
2024
Q4 | $253K | Sell |
5,640
-22
| -0.4% | -$1.23K | 0.07% | 198 |
|
|
2024
Q3 | $356K | Buy |
+5,662
| New | +$330K | 0.1% | 157 |
|
|
2024
Q2 | – | Sell |
-2,327
| Closed | -$186K | – | 331 |
|
|
2024
Q1 | $186K | Sell |
2,327
-566
| -20% | -$43.2K | 0.07% | 234 |
|
|
2023
Q4 | $228K | Sell |
2,893
-120
| -4% | -$8.54K | 0.1% | 197 |
|
|
2023
Q3 | $210K | Buy |
3,013
+16
| +0.5% | +$1.13K | 0.11% | 175 |
|
|
2023
Q2 | $207K | Buy |
2,997
+22
| +0.7% | +$1.56K | 0.1% | 182 |
|
|
2023
Q1 | $221K | Sell |
2,975
-517
| -15% | -$43.4K | 0.12% | 148 |
|
|
2022
Q4 | $325K | Sell |
3,492
-3,329
| -49% | -$321K | 0.18% | 104 |
|
|
2022
Q3 | $651K | Buy |
6,821
+18
| +0.3% | +$1.78K | 0.41% | 60 |
|
|
2022
Q2 | $630K | Sell |
6,803
-125
| -2% | -$12.2K | 0.37% | 63 |
|
|
2022
Q1 | $701K | Sell |
6,928
-340
| -5% | -$35.7K | 0.38% | 66 |
|
|
2021
Q4 | $750K | Buy |
7,268
+119
| +2% | +$11K | 0.38% | 69 |
|
|
2021
Q3 | $607K | Buy |
7,149
+184
| +3% | +$15.4K | 0.33% | 74 |
|
|
2021
Q2 | $581K | Sell |
6,965
-192
| -3% | -$15.7K | 0.32% | 77 |
|
|
2021
Q1 | $538K | Buy |
7,157
+1,435
| +25% | +$105K | 0.3% | 85 |
|
|
2020
Q4 | $390K | Sell |
5,722
-109
| -2% | -$7.09K | 0.27% | 100 |
|
|
2020
Q3 | $340K | Sell |
5,831
-13,034
| -69% | -$811K | 0.31% | 91 |
|
|
2020
Q2 | $1.23M | Sell |
18,865
-3,794
| -17% | -$239K | 1.25% | 23 |
|
|
2020
Q1 | $1.34M | Sell |
22,659
-12,089
| -35% | -$807K | 1.71% | 11 |
|
|
2019
Q4 | $2.58M | Sell |
34,748
-1,355
| -4% | -$95.1K | 1.79% | 14 |
|
|
2019
Q3 | $2.28M | Buy |
36,103
+3,636
| +11% | +$215K | 1.48% | 14 |
|
|
2019
Q2 | $1.77M | Buy |
32,467
+9,302
| +40% | +$501K | 1.19% | 20 |
|
|
2019
Q1 | $1.25M | Buy |
+23,165
| New | +$1.43M | 0.96% | 30 |
|
|
2018
Q3 | $2.23M | Buy |
28,390
+5,483
| +24% | +$392K | 1.07% | 17 |
|
|
2018
Q2 | $1.47M | Buy |
+22,907
| New | +$1.51M | 0.93% | 27 |
|
Other funds holding CVS
Truvestments Capital's CVS Position: Q2 2026 in Review
Truvestments Capital reduced its CVS Health (CVS) stake by 3.5% in Q2 2026, selling an estimated $15.4K and leaving 4,733 shares worth $490K. The position accounts for 0.07% of the portfolio, ranked #225.
Truvestments Capital first reported a position in CVS in Q2 2018 and has held it in 31 quarters since. The position peaked at $2.58M in Q4 2019. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Truvestments Capital held 4,733 shares of CVS Health worth $490K as of Q2 2026.
- Truvestments Capital sold 173 CVS Health shares in Q2 2026, an estimated $15.4K.
- CVS Health made up 0.07% of Truvestments Capital's portfolio in Q2 2026, its #225 holding.
- Truvestments Capital first reported a position in CVS Health in Q2 2018 and has held it in 31 quarters since.
- Truvestments Capital's CVS Health position peaked at $2.58M in Q4 2019.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Truvestments Capital's 13F filing for Q2 2026, filed 12 Aug 2026.